![Marc Kozin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc Kozin
Director/Board Member at
UFP TECHNOLOGIES, INC.
Net worth: 6 M $ as of 31/05/2026
Profile
Marc D.
Kozin is currently an Independent Director at UFP Technologies, Inc. since 2006, a Director at Helomics Corp., a Director at GreenLight Fund, Inc. since 2017, and an advisor at Healthcare Royalty Management LLC since 2013.
Former roles include Chairman at Vascular Biogenics Ltd. from 2021 to 2023, Director at Lynx Therapeutics, Inc. from 2002 to 2005, Independent Director at Dyax Corp.
from 2013 to 2016, Director at Medical Simulation Corp., Independent Director at Dicerna Pharmaceuticals, Inc. from 2019 to 2021, Independent Director at Flex Pharma, Inc. from 2014 to 2019, Director at AdvizeX Technologies LLC, Director at CrunchTime!.
Information Systems, Inc. from 2002 to 2013, Independent Director at Endocyte, Inc. from 2013 to 2018, Director at Chimerix, Inc. from 2024 to 2025, Director at Brandwise, Inc. from 2002 to 2005, Director at Assurance Medical, Inc. from 1999 to 2001, Independent Director at OvaScience, Inc. from 2014 to 2018, Director at DukeEngage from 2011 to 2017, Independent Director at Frequency Therapeutics, Inc. from 2016 to 2018, Independent Director at Isleworth Healthcare Acquisition Corp.
in 2021, Governor at Tufts Medical Center, Inc., and President at LEK Consulting Pty Ltd. from 1997 to 2011.
Education includes an undergraduate degree from Duke University conferred in 1983 and an MBA from The Wharton School of the University of Pennsylvania conferred in 1987.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 04/06/2026 | 28,112 ( 0.36% ) | 6 M $ | 31/05/2026 |
Marc Kozin active positions
| Companies | Position | Start |
|---|---|---|
| UFP TECHNOLOGIES, INC. | Director/Board Member | 01/01/2006 |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the field of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Consultant / Advisor | 01/01/2013 |
GreenLight Fund, Inc.
 GreenLight Fund, Inc. Miscellaneous Commercial ServicesCommercial Services Helps transform the lives of children, youth and families in high-poverty urban areas for charity | Director/Board Member | 01/01/2017 |
Helomics Corp.
 Helomics Corp. Medical/Nursing ServicesHealth Services Provides cancer care development and treatment consulting services | Director/Board Member | - |
Former positions of Marc Kozin
| Companies | Position | End |
|---|---|---|
| CHIMERIX, INC. | Director/Board Member | 21/04/2025 |
| NOTABLE LABS, LTD. | Chairman | 16/10/2023 |
| DICERNA PHARMACEUTICALS, INC. | Director/Board Member | 28/12/2021 |
| ISLEWORTH HEALTHCARE ACQUISITION CORP. | Director/Board Member | 08/09/2021 |
Flex Pharma, Inc.
 Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Director/Board Member | 19/07/2019 |
Training of Marc Kozin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
79
1st degree connections
24
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 24 |
|---|---|
UFP Technologies, Inc.
 UFP Technologies, Inc. Industrial SpecialtiesProcess Industries Engages in designing custom converting of foams, plastics, composites and natural fiber materials | Process Industries |
Lynx Therapeutics, Inc.
 Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Health Technology |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Medical Simulation Corp.
 Medical Simulation Corp. Miscellaneous Commercial ServicesCommercial Services Provides simulation training, education and consulting services to hospital personnel, medical product manufacturers & medical societies | Commercial Services |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Flex Pharma, Inc.
Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AdvizeX Technologies LLC
 AdvizeX Technologies LLC Information Technology ServicesTechnology Services Provides technology, infrastructure, cloud, data, artificial intelligence and managed services | Technology Services |
CrunchTime! Information Systems, Inc.
 CrunchTime! Information Systems, Inc. Packaged SoftwareTechnology Services Develops back-of-house operations platform for the restaurant industry | Technology Services |
Helomics Corp.
Helomics Corp. Medical/Nursing ServicesHealth Services Provides cancer care development and treatment consulting services | Health Services |
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer and inflammatory diseases | Health Technology |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the field of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Finance |
Tufts Medical Center, Inc.
 Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Offers academic medicine and research services | Health Services |
Brandwise, Inc.
 Brandwise, Inc. Packaged SoftwareTechnology Services Provides hosted software solutions | Technology Services |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Develops novel treatments for atherosclerosis and cancer | Health Technology |
Assurance Medical, Inc. | |
LEK Consulting Pty Ltd.
 LEK Consulting Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Commercial Services |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of new fertility treatment options for women | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DukeEngage | |
GreenLight Fund, Inc.
GreenLight Fund, Inc. Miscellaneous Commercial ServicesCommercial Services Helps transform the lives of children, youth and families in high-poverty urban areas for charity | Commercial Services |
Frequency Therapeutics, Inc.
 Frequency Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company which develops small molecule drugs to repair damage caused by degenerative diseases | Health Technology |
Isleworth Healthcare Acquisition Corp.
 Isleworth Healthcare Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Stock Market
- Insiders
- Marc Kozin
